Contact Information


Clinical work is often focused on one patient interaction, but the bigger picture of individual patient interactions is the field of Public Health. Pharmacists provide a unique contribution to the field through health education, disease prevention and health promotion, public health advocacy, and helping to achieve positive public health outcomes. Pharmacists are the only health care providers in the community who are accessible without charge 24 hours a day - 7 days a week. Pharmacists are the first responders in a community setting. My mission is to provide students with the knowledge, understanding and confidence to practice in multidisciplinary real world environments. My area of focus is Womens Health and my clinical practice site is Bethlehem Haven Womens Shelter.


  • Dr.PH, Epidemiology, University of Pittsburgh, 1996
  • MPH, Epidemiology, University of Pittsburgh, 1992
  • B.S. Pharmacy, University of Pittsburgh, 1986

Profile Information

  • Introduction to Biostatistics
  • Clinical Medicine and Therapeutics
  • Cardiology/Renal Module
  • Drug Literature Evaluation
  • American Health Care
  • Complementary Medicine
  • Introduction to Epidemiology
  • Public Health and Epidemiology
  • End of Life care for Patients with Substance Abuse Histories
  • Drug Herbal Interactions
  • Update in Pain Management
  • Alternative Medicine in End of Life Care
  • Pharmacoepidemiology: Is it more than just counting pills
  • End of Life Care and the Cardiac Patient
  • Managing Co-morbidities in End of Life Care
  • Update on Evidence Based Medicine-What are the guidelines
  • Research Issues in Complementary Medicine
  • Tomko R, Runyon A, Lassila H. Student self-assessed medication therapy management skills resulting from caring for uninsured patients using team-based care. Currents in Pharmacy Teaching and Learning. 2011, (3) 63-70.
  • Provenzano DA, Carvelli, A, Lassila, H. The Effect of Fluid Modulation on Radiofrequency Lessoning Size Parameters. Regional Anesthesia & Pain Medicine: July/August 2010 - Volume 35 - Issue 4 - pp 338-342
  • Lassila HC, Sutton-Tyrrell K, Schwartz F, Kuller LH. Antihypertensive Medication Use 5 Years Following the Systolic Hypertension in the Elderly Program. CVD Prevention 2000;3:229-234.
  • Matthews KA, Sutton-Tyrrell K, Wolfson SW, Lassila HC, Kuller LH: Stress-induced pulse pressure change predicts women's carotid atherosclerosis. Stroke 29(8):1525-30, 1998 August.
  • Sutton-Tyrrell K, Lassila H, Matthews KA, Meihlan E, Kuller LH: Carotid atherosclerosis in premenopausal and postmenopausal women and its association with risk factors measured after menopause. Stroke 29(6):1116-21, 1998 June.
  • Sutton-Tyrrell K, Zeigler-Johnson C, Lassila HC, Holmes J, Kuller L: Racial differences in carotid atherosclerosis among pre and postmenopausal women. CVD Prevention 1:39-47, 1998.
  • Zeigler-Johnson CM, Holmes JL, Lassila HC, Sutton-Tyrrell K, Kuller LH: Subclinical atherosclerosis in relation to hysterectomy status in African-American women. Stroke 29 (40):759-64, 1998 April.
  • Kuller LH, Meilahn EN, Lassila HC, Matthews K, Wing R. Cardiovascular risk factors during first five years postmenopause in nonhormone replacement therapy users. In Forte TM, (ed) Hormonal, Metabolic, and Cellular Influences on Cardiovascular Disease in Women. Future Publishing Company, Armonk NY, 1997.
  • Lassila HC, Sutton-Tyrrell K, Matthews KA, Wolfson SK, Kuller LH: Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women. Stroke 28:513-517, 1997.
  • Lassila HC, Stoehr GP, Gangulli M, et el.: Factors associated with the use of prescription medication in an elderly rural population: The MoVIES Project. The Annals of Pharmacotherapy 30 (6):589-95, 1996.
  • Guzick DS, Talbot EO, Sutton-Tyrrell K, Herzog HC, Kuller LH, Wolfson SK: Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Journal of Obstetrics and Gynecology 174(4):1224-9, 1996.
  • Sutton-Tyrrell K, Alcorn HG, Herzog H, Kelsy SF, Kuller LH: Morbidity, mortality and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. Stroke 26:1319-1324, 1995.